Patents
Patents for C07K 19 - Hybrid peptides (29,428)
03/2013
03/13/2013CN1606618B Novel alkali protease formed by bacillus gibsonii (DSM 14393) and washing and cleaning agents containing said novel alkali protease
03/13/2013CN102971340A Antibodies with enhanced or suppressed effector function
03/13/2013CN102965387A Trx-hPTN fusion protein and production method thereof
03/13/2013CN102965325A msCT-CTx fusion protein transgenic engineering strain
03/13/2013CN102964453A Osteogenic growth peptide-calcitonin gene related peptide fusion protein and encoding gene thereof
03/13/2013CN102964452A msCT-rhLeptin fusion protein for treating osteoporosis and obesity and nucleic acid encoding fusion protein
03/13/2013CN102964451A msCT-CTx fusion protein for treating osteoporosis and reliving pain and nucleic acid encoding fusion protein
03/13/2013CN102964450A OGP-AcAP2 (Osteogenic Growth Peptide) fusion protein for treating osteoporosis and thrombus and nucleic acid for coding fusion protein
03/13/2013CN102961761A Quantum dot targeting probe for colorectal cancer tumor tissue identification and preparation method thereof
03/13/2013CN102321179B Hepatitis C virus recombination protein and gene sequence
03/13/2013CN102234657B Fusion protein for resisting chicken coccidiosis, preparation and application thereof
03/13/2013CN101962413B Fusion protein with transdermal capability and interleukin-10 activity as well as coding gene and application thereof
03/13/2013CN101597335B Recombined protein specially combined with fiber protein and application thereof
03/13/2013CN101492507B Complex of Fab fragment of C2H7 and CD20 antigen epitope polypeptide
03/13/2013CN101302256B Novel recombinant fusion molecule and antineoplastic treatment function thereof
03/12/2013US8394771 Multimeric proteins and methods of making and using same
03/12/2013CA2479927C Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
03/12/2013CA2407910C Antibodies that immunospecifically bind to blys
03/07/2013WO2013033658A1 Self-assembled nanostructures
03/07/2013WO2013033363A1 Mycobacterium tuberculosis porins and toxins and related methods
03/07/2013WO2013033104A1 CONTROLLING ALLERGY AND ASTHMA BY ACTIVATING HUMAN DCs VIA DECTIN-1 OR DECTIN-1 AND TOLL-LIKE RECEPTOR 2 (TLR2)
03/07/2013WO2013032012A1 Glycosylated polypeptide and drug composition containing said polypeptide
03/07/2013WO2013032011A1 Glycosylated polypeptide and drug composition containing said polypeptide
03/07/2013WO2013031882A1 Vaccine preparation for cancer treatment
03/07/2013WO2013029205A1 Cleavable protein of interferon fused with human serum albumin and encoding gene and use thereof
03/07/2013WO2013009690A3 Leukemia stem cell targeting ligands and methods of use
03/07/2013US20130060010 Design and development of masked therapeutic antibodies to limit off-target effects
03/07/2013US20130059793 Egf receptor mimicking peptides
03/07/2013US20130059785 Gene and Polypeptide Sequences
03/07/2013US20130059780 Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
03/07/2013US20130059752 Compositions and methods for the treatment of immune related diseases
03/07/2013US20130058994 Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis
03/07/2013US20130058962 Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein
03/07/2013US20130058908 High affinity ny-eso t cell receptors
03/07/2013US20130058873 P97 fragments with transfer activity
03/07/2013CA2847527A1 Bmp peptides & methods of use
03/07/2013CA2847442A1 Mycobacterium tuberculosis porins and toxins and related methods
03/07/2013CA2847336A1 Glycosylated polypeptide and drug composition containing said polypeptide
03/07/2013CA2847334A1 Glycosylated polypeptide and drug composition containing said polypeptide
03/07/2013CA2847332A1 Vaccine preparation for cancer treatment
03/07/2013CA2847173A1 Viral clearance methods
03/07/2013CA2846852A1 Fap-activated proteasome inhibitors for treating solid tumors
03/06/2013EP2563912A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
03/06/2013EP2563911A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
03/06/2013EP2563817A2 Fluorescent fusion polypeptides and methods of use
03/06/2013EP2563808A1 Peptide conjugates of glp-1 receptor agonists and gastrin and their use
03/06/2013CN102952836A Recombinant human long-acting interleukin-1 receptor antagonist fusion protein purification method
03/06/2013CN102952193A Antigenic epitope displaying method based on single domain antibody
03/06/2013CN102952192A Fusion protein containing Exendin-4 and application thereof
03/06/2013CN102250255B Genetic engineering protein TAT-VP28-GH capable of resisting white spot syndrome virus (WSSV) as well as preparation and application thereof
03/06/2013CN102241778B PPA-linker-Thanatin fusion protein and preparation method thereof
03/06/2013CN101511868B Exendin fusion proteins
03/05/2013US8389690 Antibodies to JTT-1 protein and cells secreting such antibodies
02/2013
02/28/2013WO2013028996A1 Self-assembled bead-based multiplexed assay for antigen-specific antibodies
02/28/2013WO2013027796A1 IgG-BINDING PEPTIDE AND METHOD FOR DETECTING AND PURIFYING IgG USING SAME
02/28/2013WO2013027217A1 Zymoxins and methods of using the same
02/28/2013WO2013026334A1 Cell dna synthesis prevention and cell proliferation inhibition polypeptide and use thereof
02/28/2013WO2013026105A1 Pest-controlling agents isolated from spider venom and uses thereof
02/28/2013WO2012159006A3 Polypeptides and vectors for targeting her2/neu expressing cells and uses thereof
02/28/2013US20130053544 Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds
02/28/2013US20130053322 Hsa-related compositions and methods of use
02/28/2013US20130053271 Self-Assembled Bead-Based Multiplexed Assay For Antigen-Specific Antibodies
02/28/2013US20130052229 Compounds and methods for diagnosis and immunotherapy of tuberculosis
02/28/2013US20130052217 Tumor vaccination involving a humoral immune response against self-proteins
02/28/2013US20130052216 Targeted heterologous antigen presentation on calicivirus virus-like particles
02/28/2013US20130052213 Novel immunomodulatory peptide
02/28/2013US20130052193 CONTROLLING ALLERGY AND ASTHMA BY ACTIVATING HUMAN DCs VIA DECTIN-1 OR TOLL-LIKE RECEPTOR 2 (TLR2)
02/28/2013US20130052192 Activatable Constructs
02/28/2013US20130052182 Method of reducing biofilms
02/28/2013US20130052135 Molecules With Extended Half-Lives, Compositions And Uses Thereof
02/28/2013CA2846197A1 Novel kif5b-ret fusion molecules and uses thereof
02/27/2013EP2560684A1 Fibronectin type iii domain-based multimeric scaffolds
02/27/2013CN102947341A Engineered opsonin for pathogen detection and treatment
02/27/2013CN102947324A Peptide domains that bind small molecules of industrial significance
02/27/2013CN102942618A Telomeric protein polypeptide fragment with tumor cell killing activity and application thereof
02/27/2013CN102942616A Peptide capable of binding to immunoglobulin
02/27/2013CN102940880A Growth factor complex
02/26/2013CA2674885C Anti-ige vaccines
02/26/2013CA2674837C Anti-ige vaccines
02/26/2013CA2633345C A method of affinity separation and ligands for use therein
02/26/2013CA2524399C Optimized fc variants and methods for their generation
02/26/2013CA2493822C Methods and compositions for targeting secretory lysosomes
02/26/2013CA2380302C Production of proteins by autoproteolytic cleavage
02/26/2013CA2327586C Fap.alpha.-specific antibody with improved producibility
02/21/2013WO2013025846A2 Transferrin-tumstatin fusion protein and methods for producing and using the same
02/21/2013WO2013025079A1 Method for preparing active form of tnfr-fc fusion protein
02/21/2013WO2013025052A2 Bioactive carbon nanotube composite functionalized with β-sheet polypeptide block copolymer, and preparation method thereof
02/21/2013US20130045922 Pro-angiogenic fragments of prominin-1 and uses thereof
02/21/2013US20130045917 Method of selecting polypeptide sequence, and metal oxide or silicon-containing compound binding peptide and use thereof
02/21/2013US20130045205 Methods and Compositions Related to Glycoprotein-Immunoglobulin Fusions
02/21/2013CA2849015A1 Transferrin-tumstatin fusion protein and methods for producing and using the same
02/21/2013CA2845536A1 Anti-b7-h4 antibodies and their uses
02/20/2013EP2558503A1 Compositions and methods for brain delivery of analgesic peptides
02/20/2013CN102939303A Tetravalent cd47-antibody constant region fusion protein for use in therapy
02/20/2013CN102936288A Erythropoietin mimetic peptide fusion protein and mutant
02/20/2013CN102936281A RTRAIL(recombinant TNF(tumor necrosis factor) related apoptosis-inducing ligand) mutant and monomethyl auristatin E(MMAE) conjugate thereof
02/20/2013CN102936278A Epitope polypeptide of dengue virus type 2 NS3 protein and application thereof
02/20/2013CN102936277A Human blood vessel endothelial growth factor antigen epitope and epitope vaccine thereof
02/19/2013CA2512780C Multivalent constructs that bind the vegf receptor-2 kdr for therapeutic and diagnostic applications
02/19/2013CA2485120C Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 295